← Open Payments lookup

CARLEY BUDDENBAUM: Open Payments

NPI 1982174074 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$5,261 in 251 payments from 22 companies in 2025. Trend: 2023 $3,410 · 2024 $5,117 · 2025 $5,261

Food & beverage: $5,200Education: $61
CompanyPaymentsAmount
ABBVIE INC.49$998
Janssen Biotech, Inc.23$612
PFIZER INC.16$389
GENZYME CORPORATION17$385
Galderma Laboratories, L.P.22$384
Novartis Pharmaceuticals Corporation15$381
SUN PHARMACEUTICAL INDUSTRIES INC.13$287
Amgen Inc.15$275
Regeneron Healthcare Solutions, Inc.14$244
Lilly USA, LLC11$196

Products named: DUPIXENT, TREMFYA, SKYRIZI, RINVOQ, NEMLUVIO, CIBINQO, COSENTYX, TALTZ.

Industry payments across TX — which companies pay providers there.